Cargando…

Application of complex and chemically-defined medium supplements toward cell line specific performance enhancement of biopharmaceutical production systems

Detalles Bibliográficos
Autores principales:	Babcock, James F, Benedict, Karen A, Perlman, Amanda L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284951/ https://www.ncbi.nlm.nih.gov/pubmed/22373248 http://dx.doi.org/10.1186/1753-6561-5-S8-P25

Ejemplares similares

Complex medium supplements optimized for the reduction of animal-derived components in vaccine production media
por: Babcock, James F, et al.
Publicado: (2011)

A comparison of performance enhancing synergy among ultrafiltered yeast extracts and recombinant human serum albumin in CHO-K1 cells
por: Babcock, James F, et al.
Publicado: (2011)

Development of a chemically defined CHO medium by engineering based on a feed solution
por: Landauer, Karlheinz, et al.
Publicado: (2011)

Fluorescence-based tools to improve biopharmaceutical process development
por: Duarte, Tiago M, et al.
Publicado: (2011)

Highly efficient, chemically defined and fully scalable biphasic production of vaccine viruses
por: Jordan, Ingo, et al.
Publicado: (2011)

Towards rational engineering of cells: Recombinant gene expression in defined chromosomal loci
por: Nehlsen, Kristina, et al.
Publicado: (2011)

Defining dosage
por: Pellis, Tommaso
Publicado: (2015)

DNA as a medium for hiding data
por: Beck, Marc, et al.
Publicado: (2012)

10(th) European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals
por: Tourdot, S., et al.
Publicado: (2020)

Development of a chemically defined cultivation and transfection medium for HEK cell lines
por: Püngel, Sebastian, et al.
Publicado: (2013)

Introducing a new chemically defined medium and feed for hybridoma cell lines
por: Heinrich, Christoph, et al.
Publicado: (2013)

Chemically defined medium and Caenorhabditis elegans
por: Szewczyk, Nathaniel J, et al.
Publicado: (2003)

Are supranormal values of DO(2) defined well?
por: Kula , R, et al.
Publicado: (1999)

Strategies for adaptation of mAb-producing CHO cells to serum-free medium
por: Costa, A Rita, et al.
Publicado: (2011)

Improvement of Preimplantation Development of In Vitro-Fertilized Bovine Zygotes by Glucose Supplementation to a Chemically Defined Medium
por: SAKAGAMI, Nobutada, et al.
Publicado: (2014)

Medium and feed optimization for fed-batch production of a monoclonal antibody in CHO cells
por: Kochanowski, Nadine, et al.
Publicado: (2011)

Specificity of the T Cell Response to Protein Biopharmaceuticals
por: Meunier, Sylvain, et al.
Publicado: (2020)

Novel human partner cell line for immortalisation of rare antigen-specific B cells in mAb development
por: Kaseko, Galina, et al.
Publicado: (2011)

Localisation of MHC Class II/HC gp-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies
por: Baeten, D, et al.
Publicado: (2003)

Micronutrient supplementation for cancer prevention
por: Kristal, Alan
Publicado: (2015)

Perceptions of primary care professionals about sharing patient care with endocrinologist medium sized-city
por: Duvoisin, Andrea CBB, et al.
Publicado: (2015)

Advantages of critical care ultrasound in primary survey: the experience of a medium size Emergency Department
por: Zanatta, M, et al.
Publicado: (2014)

A Chemically Defined Medium for Rabbit Embryo Cryopreservation
por: Bruyère, Pierre, et al.
Publicado: (2013)

Delay in anal cancer diagnosis as a non-AIDS-defining malignancy
por: Cohen, Justine, et al.
Publicado: (2010)

Non-AIDS-defining cancer mortality among people with AIDS in Italy
por: Zucchetto, Antonella, et al.
Publicado: (2010)

Transient gene expression with CHO cells in conditioned medium: a study using TubeSpin(®) bioreactors
por: Pereira, João, et al.
Publicado: (2011)

An exploration of the 3D chemical space has highlighted a specific shape profile for the compounds intended to inhibit protein-protein interactions
por: Kuenemann, Mélaine A, et al.
Publicado: (2015)

KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma
por: Cavallin, Lucas E, et al.
Publicado: (2010)

Announcing the 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology: March 8–11, 2010, Malta
por: Siepmann, Juergen
Publicado: (2009)

Strategies in umbilical cord-derived mesenchymal stem cells expansion: influence of oxygen, culture medium and cell separation
por: Lavrentieva, Antonina, et al.
Publicado: (2011)

Detection of rheumatoid arthritis-specific anti-filaggrin antibodies by line immunoassay shows complementarity to RF and corresponds to the AFA-blot using natural antigen
por: Union, A, et al.
Publicado: (2001)

Utilization of Site-Specific Recombination in Biopharmaceutical Production
por: Ahmadi, Maryam, et al.
Publicado: (2016)

Defining hypotension in the emergency department and in the pre-hospital setting: A hospital-based cohort study
por: Kristensen, Anders KB, et al.
Publicado: (2015)

Association between foot types defined by static and dynamic measures, and the centre of pressure during gait
por: Liao, Su, et al.
Publicado: (2014)

Improvement of stem cell performance by supplementation with metabolic enhancers
por: Abitorabi, Abi M, et al.
Publicado: (2011)

Biopharmaceuticals : biochemistry and biotechnology
por: Walsh, Gary
Publicado: (2003)

Biopharmaceuticals : biochemistry and biotechnology /
por: Walsh, Gary
Publicado: (1998)

A subset of memory effector T cells in peripheral blood defined by differential expression of the TCR-ζ chain
por: Zhang, Z, et al.
Publicado: (2003)

Defining quality indicators for practices, instruments, and programs across the JJ-TRIALS behavioral health services cascade
por: Wasserman, Gail, et al.
Publicado: (2015)

Pericentromeric demethylation and chromosomal instability induced by chemicals
por: Prada, Diddier, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_sg5q5hjegpe8rj1ksqak9hojvb